82476-3
Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Active
Term Description
The DNA amplification target is a gene encoding glycerophosphodiester phosphodiesterase (GlpQ), which is specific to the Borrelia species in the relapsing fever group. This gene is not found in the Borrelia species that cause Lyme disease. Melting curve analysis is then used to identify the B. miyamotoi organism. A positive result is consistent with active or recent infection. B. miyamotoi infections of the central nervous system are associated with the symptoms and signs of meningoencephalitis.
Source: Regenstrief LOINC
Part Description
LP221168-0 Borrelia miyamotoi glpQ gene
Borrelia miyamotoi is a spirochetal bacterium that is closely related to the Borrelia species that causes tick-borne relapsing fever (TBRF), and it is more distantly related to the Borrelia species that cause Lyme disease. First identified in 1995 in ticks from Japan, B. miyamotoi has since been detected in two species of North American ticks, the black-legged or "deer" tick (Ixodes scapularis) and the western black-legged tick (Ixodes pacificus). These ticks are already known to transmit several diseases, including Lyme disease, anaplasmosis, and babesiosis. Patients with B. miyamotoi infection are most likely to have fever, chills, and headache. Other common symptoms included body and joint pain and fatigue. Unlike Lyme disease, rash is uncommon, presenting in only 4 out of 51 patients. Patients infected with B. miyamotoi have been treated with a 2-4 week course of doxycycline, amoxicillin, or ceftriaxone. Fewer than 60 well-documented cases of human infection have been reported in the United States as of July 2015. The route of transmission of B. miyamotoi to humans has not been firmly established, but likely involves the bite of infected black-legged ticks. The glpQ gene encodes a periplasmic enzyme, glycerophosphodiester phosphodiesterase of 333 amino acids produced initially with a 25 residue long signal sequence. GlpQ is not found in Borrelia species that cause Lyme disease.
Source: Regenstrief LOINC, CDC: B. miyamotoi
Fully-Specified Name
- Component
- Borrelia miyamotoi glpQ gene
- Property
- PrThr
- Time
- Pt
- System
- CSF
- Scale
- Ord
- Method
- Non-probe.amp.tar
Additional Names
- Long Common Name
- Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection
- Short Name
- B miyamotoi glpQ CSF Ql NAA+non-probe
- Display Name
- B. miyamotoi glpQ gene NAA+non-probe Ql (CSF)
- Consumer Name Alpha Get Info
- Borrelia miyamotoi glpQ gene, Spinal fluid
Example Answer List: LL360-9
Source: Regenstrief InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.58
- Last Updated
- Version 2.68
- Change Reason
- Release 2.68: COMPONENT: Removed parentheses around the bacterial gene name based on current LONC naming model.; Previous Releases:
- Order vs. Observation
- Both
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG41633-5 | Borrelia |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen glpQ de Borrelia miyatomoi: |
es-MX | Spanish (Mexico) | Gen glpQ de Borrelia miyamotoi: |
fr-FR | French (France) | Borrelia miyamotoi glpQ gène: |
it-IT | Italian (Italy) | Borrelia miyamotoi (glpQ), gene: Synonyms: Amplificazione target non basata su sonda Gene Borrelia miyamotoi (glpQ) Liquido cerebrospinale Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA |
zh-CN | Chinese (China) | 宫本疏螺旋体 glpQ 基因: Synonyms: CSF CSF; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=82476-3
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://